FindTrial
Sign In

Vitamin D Pilot Study in Patients With Multiple Sclerosis

Vitamin D Pilot Study in Patients With Multiple Sclerosis

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01257958
Enrollment
Unknown
Registered
2010-12-10
Start date
1998-02-28
Completion date
2000-06-30
Last updated
2015-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsing Remitting Multiple Sclerosis

Keywords

Vitamin D, 19 nor Vitamin D, Multiple Sclerosis

Brief summary

Phase 1 study of 19-nor Vitamin D in relapsing-remitting MS. Primary measure is MRI.

Interventions

DRUG19 nor vitamin d

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* relapsing remitting MS

Exclusion criteria

* MRI contraindicated

Design outcomes

Primary

MeasureTime frame
MRI Measure of new active lesions, observation vs. treatment—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026